Income Statement
TYRA BIOSCIENCES, INC.
TYRA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
132.76 | 104.18 | 79.95 | 58.93 | 26.29 |
|
Research & Development
|
102.93 | 80.08 | 62.52 | 43.01 | 20.64 |
|
Selling, General & Administrative
|
29.83 | 24.10 | 17.43 | 15.92 | 5.65 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-132.76 | -104.18 | -79.95 | -58.93 | -26.29 |
|
Non-Operating Income
|
12.82 | 17.70 | 10.81 | 3.60 | -0.01 |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-119.95 | -86.48 | -69.13 | -55.33 | -26.29 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-132.22 | -103.66 | -79.59 | -58.63 | -26.15 |
|
Earnings Per Share (Basic)
|
-2.01 | -1.51 | -1.62 | -1.32 | - |
|
Diluted EPS
|
-2.01 | -1.51 | -1.62 | -1.32 | - |
|
Weighted Average Shares
|
59.60 | 57.22 | 42.70 | 41.88 | - |
|
Diluted Weighted Avg Shares
|
59.60 | 57.22 | 42.70 | 41.88 | - |
|
Comprehensive Income
|
-120.32 | -86.09 | -68.75 | - | - |